![]() |
市場調查報告書
商品編碼
1762327
胎盤市場,規模,佔有率,趨勢,產業分析報告:類別,各用途,各地區,2025年~2034年的市場預測Placenta Market Size, Share, Trends, Industry Analysis Report: By Type (Porcine, Equine, Ovine, and Others), Application, and Region (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America) - Market Forecast, 2025-2034 |
根據 Polaris Market Research 的最新研究,預計到 2034 年,全球胎盤市場規模將達到 14.0487 億美元。該報告深入分析了當前的市場動態,並分析了未來的市場成長。
胎盤組織及其萃取物在生殖醫學中用於促進子宮健康、提高胚胎著床率並增強整體生育能力。接受體外受精 (IVF) 等輔助生殖技術 (ART) 的夫婦越來越多地選擇基於胎盤的治療來提高受孕幾率。臨床研究表明,胎盤萃取物中的生物活性化合物可以改善子宮內膜容受性,從而提高胚胎著床的成功率。由於生活方式改變、壓力和受孕延遲等因素導致不孕不育率持續上升,對胎盤衍生不孕症治療等創新解決方案的需求預計將增長。因此,胎盤在生育治療的應用日益廣泛,促進了胎盤市場的成長。
人們對胎盤在皮膚病學、毛髮學和生殖醫學應用的認識不斷提高,並持續刺激了需求。斑禿越來越普遍,尤其是在女性和某些種族中,這增加了對利用胎盤再生特性的先進療法的需求。正在進行的科學研究正在增強胎盤產品的功效,擴大其在醫療和化妝品領域的應用。
隨著醫療和化妝品行業對胎盤衍生產品的需求不斷增長,胎盤市場正在迅速擴張。從抗衰老護膚到護髮和生育治療,胎盤萃取物的應用正在推動創新和投資。人們對天然、科學支持的解決方案日益增長的偏好,刺激了對胎盤的需求。各公司不斷開發新的配方,推動市場擴張。持續的進步使胎盤市場在美容、健康和保健行業中始終佔據重要地位。
按類型劃分,由於豬胎盤用途廣泛且易於獲取,2024年豬胎盤佔據了胎盤市場佔有率的主導地位。豬胎盤因其富含膠原蛋白、蛋白質和活性勝肽,已成為市場上的寶貴資源。
按應用劃分,預計製藥領域在預測期內的複合年增長率最高。在製藥領域,胎盤萃取物因其治療特性而備受研究。其富含生長因子、細胞激素和細胞外囊泡等生物活性分子,使其成為治療應用的有希望的候選材料。
由於對胎盤類化妝品、膳食補充劑和藥品的需求不斷增長等因素,北美在 2024 年佔據了全球胎盤市場收入佔有率的主導地位。
由於肌肉營養不良症等罕見疾病的盛行率上升以及對胎盤補充劑的需求不斷增長,預計未來幾年亞太市場將實現最高的複合年增長率。
The global placenta market size is expected to reach USD 1,404.87 million by 2034, according to a new study by Polaris Market Research. The report "Placenta Market Size, Share, Trends, Industry Analysis Report: By Type (Porcine, Equine, Ovine, and Others), Application, and Region (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Placental tissues and extracts are utilized in reproductive medicine to enhance uterine health, improve embryo implantation rates, and support overall fertility. Couples undergoing assisted reproductive technologies (ART), such as in-vitro fertilization (IVF), are increasingly turning to placenta-based treatments to enhance their chances of conception. Clinical research suggests that bioactive compounds found in placental extracts improve endometrial receptivity, making embryo implantation more successful. As infertility rates continue to rise due to factors such as lifestyle changes, stress, and delayed pregnancies, the need for innovative solutions such as placenta-derived fertility treatments is expected to grow. Thus, the expanding use of the placenta in fertility treatments is contributing to placenta market growth.
The rising awareness of placenta applications in dermatology, trichology, and reproductive medicine continues to fuel demand. With alopecia areata becoming more prevalent, particularly among women and certain ethnic groups, the need for advanced treatments utilizing the placenta's regenerative properties is growing. Ongoing scientific research is enhancing the effectiveness of placenta-based products, broadening their use across medical and cosmetic fields.
The placenta market is expanding rapidly as demand for placenta-derived products grows across the medical and cosmetic industries. From antiaging skincare to hair care and fertility treatments, the use of placental extracts is driving innovation and investment. The increasing preference for natural and scientifically backed solutions is fueling the placenta market demand. Companies are continuously developing new formulations, driving the market expansion. Ongoing advancements keep the market a significant player in the beauty, health, and wellness industries.
Based on type, the porcine segment dominated the placenta market share in 2024 due to its versatility and availability of porcine placenta. Porcine (pig) placenta is emerging as a valuable resource in the market, owing to its rich composition of collagen, proteins, and bioactive peptides.
The pharmaceuticals segment, by application, is estimated to register the highest CAGR during the forecast period. In the pharmaceutical segment, placental extracts have been explored for their therapeutic properties. The rich composition of bioactive molecules such as growth factors, cytokines, and extracellular vesicles makes placental extracts promising candidates for therapeutic applications.
North America dominated the global placenta market revenue share in 2024 due to factors such as increasing demand for placenta-based cosmetics, health supplements, and pharmaceutical products.
The market in Asia Pacific is expected to register the highest CAGR in the coming years owing to rising prevalence of rare diseases such as muscular dystrophy and growing demand for placenta-based supplements.
A few global key market players are Japan Natural Laboratories Co., Ltd.; Japan Bio Products Co., Ltd.; Albert David Limited; Atlanta Placenta Encapsulation; MIMEDX Group, Inc.; PURTIER Placenta; The Placenta Company; Smith and Nephew; Mommy Made Encapsulation; and Nubloom LLC.
Polaris Market Research has segmented the placenta market report on the basis of type, application, and region:
By Type Outlook (Revenue, USD Million, 2020-2034)
Porcine
Equine
Ovine
Others
By Application Outlook (Revenue, USD Million, 2020-2034)
Pharmaceuticals
Cosmetics
Supplements
Others
By Regional Outlook (Revenue, USD Million, 2020-2034)
North America
US
Canada
Mexico
Europe
Germany
France
UK
Russia
Italy
Spain
Netherlands
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
Israel
UAE
Rest of Middle East & Africa
Latin America
Brazil
Mexico
Argentina
Rest of Latin America